Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT Capsules for Recurrent Clostridioides Difficile Infection
NCT07458984Phase 3Recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of Fecal Microbiota Transplantation Capsule in Clostridioides difficile infection (CDI), sponsored by Helsinki University Hospital. Started Apr 2026; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT07458984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07458984.